Nuformix (NFX)

Sector:

Pharma and Biotech

0.20p
   
  • Change Today:
      0.033p
  • 52 Week High: 0.22
  • 52 Week Low: 0.048
  • Currency: UK Pounds
  • Shares Issued: 1,669.31m
  • Volume: 188,215,605
  • Market Cap: £3.26m
  • RiskGrade: 322

Nuformix Overview

Nuformix is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing. We use our expertise in discovering, developing and patenting novel drug forms with improved physical properties, to develop new products in new indications that are differentiated from the original by way of: dosage, delivery route or presentation, thus creating new and attractive commercial opportunities.
Competitors: Hemogenyx Pharmaceuticals

Key Personnel

Executive Director: Daniel Gooding
Independent Non-Executive Director: Madeleine Kennedy
Non-Executive Chairman: Julian Gilbert
Non-Executive Dir:

Contact Details

Address: C/O Arch Law Limited, Huckletree Bishopsgate, 8 Bishopsgate, London, United Kingdom, EC2N 4BQ
Phone: +44 (0)1223 627222
Website: https://nuformix.com/

Listings

Sector: Pharma and Biotech(LSE)
ISIN: GB00BYW79Y38

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Nuformix Market Data

Currency UK Pounds
Share Price 0.20p
Change Today 0.033p
% Change 20.00 %
52 Week High 0.22
52 Week Low 0.048
Volume 188,215,605
Shares Issued 1,669.31m
Market Cap £3.26m
RiskGrade 322

Nuformix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
41.74% below the market average41.74% below the market average41.74% below the market average41.74% below the market average41.74% below the market average
23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average23.40% above the sector average
Price Trend
10.92% above the market average10.92% above the market average10.92% above the market average10.92% above the market average10.92% above the market average
57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average57.45% above the sector average
Income Not Available
Growth Not Available

Nuformix Dividends

No dividends found

Trades for 29-May-2025

Time Volume / Share Price
08:58 2,000,000 @ 0.14p
08:57 622,111 @ 0.14p
08:57 746,663 @ 0.14p
08:56 1,800,295 @ 0.14p
08:56 1,184,553 @ 0.14p

Top of Page